Breast cancer cell targeted MR molecular imaging probe: Anti-MUC1 antibody-based magnetic nanoparticles

Khaniabadi, Pegah Moradi; Majid, Abdul; Asif, Muhammad; Khaniabadi, Bita Moradi; Shahbazi‐Gahrouei, Daryoush; Jaafar, Mohammad Suhaimi

doi:10.1088/1742-6596/851/1/012014

Cited by 9 publications

(8 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…SPIONs, ultrasmall SPIONs, Gd-encapsulated silicon microparticles, and Gd-ion-doped upconversion nanoparticles (UCNPs) are mainly domain of MRI contrast agents. [3]…”

Section: Magnetic Resonance Imagingmentioning

confidence: 99%

“…MI probes include targeting components such as antibodies,[23] dendrimers,[4] aptamers,[5] peptides,[6] or small molecules and signaling components, including radionuclides, fluorochromes for optical imaging, or paramagnetic chelates for magnetic resonance imaging (MRI). [78] Nanosized probes with unique properties have emerged as a potential class of MI.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings

Shahbazi‐Gahrouei

Khaniabadi

et al. 2019

J Res Med Sci

View full text Add to dashboard Cite

Medical imaging modalities are used for different types of cancer detection and diagnosis. Recently, there have been a lot of studies on developing novel nanoparticles as new medical imaging contrast agents for the early detection of cancer. The aim of this review article is to categorize the medical imaging modalities accompanying with using nanoparticles to improve potential imaging for cancer detection and hence valuable therapy in the future. Nowadays, nanoparticles are becoming potentially transformative tools for cancer detection for a wide range of imaging modalities, including computed tomography (CT), magnetic resonance imaging, single photon emission CT, positron emission tomography, ultrasound, and optical imaging. The study results seen in the recent literature provided and discussed the diagnostic performance of imaging modalities for cancer detections and their future directions. With knowledge of the correlation between the application of nanoparticles and medical imaging modalities and with the development of targeted contrast agents or nanoprobes, they may provide better cancer diagnosis in the future.

show abstract

“…SPIONs, ultrasmall SPIONs, Gd-encapsulated silicon microparticles, and Gd-ion-doped upconversion nanoparticles (UCNPs) are mainly domain of MRI contrast agents. [3]…”

Section: Magnetic Resonance Imagingmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings

Shahbazi‐Gahrouei

Khaniabadi

et al. 2019

J Res Med Sci

View full text Add to dashboard Cite

show abstract

“…In recent years, using nanoparticle and nanotechnology are interested among researchers to increase MR image contrast in particular for cancer detection in early stages. The most representative negative contrast agents are superparamagnetic iron oxide nanoparticles (SPIONs), ultrasmall superparamagnetic iron oxide nanoparticles (USPIONs), Gdencapsulated silicon micro-particles, Gd-ion doped upconversion nanoparticles (UCNPs), while typical positive contrast agents include small molecular weight compounds involving a single lanthanide chelate as signal producing element [5,76].…”

Section: Magnetic Resonance Imagingmentioning

confidence: 99%

“…Moradi Khaniabadi et al [4,5] conducted a study on SPIONs conjugated with C595 Mab, MR T 2 contrast agent for early detection of overexpressed MUC1 breast cancer. The findings demonstrated that MR images significantly enhanced the intensity of T 1 and T 2 relaxation times of breast cancer cells.…”

Section: Magnetic Resonance Imagingmentioning

confidence: 99%

See 1 more Smart Citation

A literature review on multimodality molecular imaging nanoprobes for cancer detection

Shahbazi‐Gahrouei

Khaniabadi

Shahbazi-Gahrouei

et al. 2019

Polish Journal of Medical Physics and Engineering

View full text Add to dashboard Cite

Molecular imaging techniques using nanoparticles have significant potential to be widely used for the detection of various types of cancers. Nowadays, there has been an increased focus on developing novel nanoprobes as molecular imaging contrast enhancement agents in nanobiomedicine. The purpose of this review article is to summarize the use of a variety of nanoprobes and their current achievements in accurate cancer imaging and effective treatment. Nanoprobes are rapidly becoming potential tools for cancer diagnosis by using novel molecular imaging modalities such as Ultrasound (US) imaging, Computerized Tomography (CT), Single Photon Emission Tomography (SPECT) and Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and Optical Imaging. These imaging modalities may facilitate earlier and more accurate diagnosis and staging the most of cancers.

show abstract

Nanomaterials for Early Cancer Diagnostics

Kumar

Kumari

Rathee

et al. 2021

Nanomedicine for Cancer Diagnosis and Therapy

View full text Add to dashboard Cite

Breast cancer cell targeted MR molecular imaging probe: Anti-MUC1 antibody-based magnetic nanoparticles

Cited by 9 publications

References 25 publications

Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings

Medical imaging modalities using nanoprobes for cancer diagnosis: A literature review on recent findings

A literature review on multimodality molecular imaging nanoprobes for cancer detection

Nanomaterials for Early Cancer Diagnostics

Contact Info

Product

Resources

About